Literature DB >> 18192448

NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?

C Scarpignato1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18192448     DOI： 10.1136/gut.2007.134502

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  15 in total

1.  Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.

Authors:  Mario Guslandi
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

Review 2.  NSAID enteropathy: could probiotics prevent it?

Authors:  Massimo Montalto; Antonella Gallo; Antonio Gasbarrini; Raffaele Landolfi
Journal:  J Gastroenterol       Date:  2012-08-09       Impact factor: 7.527

Review 3.  Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.

Authors:  Antonella Gallo; Giovanna Passaro; Antonio Gasbarrini; Raffaele Landolfi; Massimo Montalto
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

Review 4.  Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition.

Authors:  Carmelo Scarpignato; Ingvar Bjarnason
Journal:  Curr Gastroenterol Rep       Date:  2019-11-13

5.  Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.

Authors:  Hiroki Endo; Takuma Higurashi; Kunihiro Hosono; Eiji Sakai; Yusuke Sekino; Hiroshi Iida; Yasunari Sakamoto; Tomoko Koide; Hirokazu Takahashi; Masato Yoneda; Chikako Tokoro; Masahiko Inamori; Yasunobu Abe; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2011-05-10       Impact factor: 7.527

6.  Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice.

Authors:  Amanda LoGuidice; Bret D Wallace; Lauren Bendel; Matthew R Redinbo; Urs A Boelsterli
Journal:  J Pharmacol Exp Ther       Date:  2012-02-10       Impact factor: 4.030

7.  Cell-free probiotic supernatant (CFS) treatment alleviates indomethacin-induced enterocolopathy in BALB/c mice by down-modulating inflammatory response and oxidative stress: potential alternative targeted treatment.

Authors:  Arezki Samer; Ryma Toumi; Imene Soufli; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2022-05-04       Impact factor: 5.093

Review 8.  Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.

Authors:  Ingvar Bjarnason; Ken Takeuchi
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model.

Authors:  Satoshi Kurata; Takako Nakashima; Takako Osaki; Naoya Uematsu; Masafumi Shibamori; Kazushi Sakurai; Shigeru Kamiya
Journal:  J Clin Biochem Nutr       Date:  2014-10-04       Impact factor: 3.114

10.  Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy.

Authors:  Suzanne M Abimosleh; Cuong D Tran; Gordon S Howarth
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.